Velvakiment

纬瓦奇茉单抗

Report date: 2026/04/17 20:02:02

Base Information

Drug NameVelvakiment
Drug Alias NameAntibody VH domain therapeutic (Zai lab)HumabodyZL-1102CB-001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-domain antibody (Nanobody)
Mechanisms of ActionInterleukin 17A inhibitorsImmunostimulants
TargetsInterleukin 17A
Therapy Area/IndicationsPlaque psoriasisPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesCrescendo Biologics Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesZai Lab (Hong Kong) LtdZai Lab (Us) LlcZai Lab (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsPlaque psoriasisPsoriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A